Efficacy of Filgotinib in Moderate to Severe Ulcerative Colitis: A Prospective Study Using Partial Mayo Score, Ulcerative Colitis Endoscopic Index of Severity, and Geboes Histopathology Score
Filgotinib appears to be an effective treatment for UC, demonstrating potential for achieving not only clinical remission but also endoscopic and histopathological remission.
Authors
- Yutaro Mihara (ORCID: https://orcid.org/0000-0002-4119-1486)
- Hideki Ishibashi (ORCID: https://orcid.org/0000-0003-3535-2906)
- Yuko Sakakibara (ORCID: https://orcid.org/0000-0001-8063-8781)
- Yoshiyuki Shirouzu
- Keiichi Mitsuyama (ORCID: https://orcid.org/0000-0002-5959-9607)
- Hidetoshi Takedatsu (ORCID: https://orcid.org/0000-0002-0318-0129)
- Asami Suzuki
- Toshihiro Noake
- Masayoshi Kage
- Kazuyoshi Nagata (ORCID: https://orcid.org/0000-0002-6242-172X)
- Tomoko Irie
- Toshihiro Ohmiya
- Yasumi Araki
Institutions
- Kurume University (JP)
- Kurume University Hospital (JP)
Publication Details
- Journal
- Crohn s & Colitis 360
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1093/crocol/otaf030
- Citations
- 2
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 3.63